Phase I Dose-Escalation Study Of Azacitidine In Combination With Temozolomide

NCT00629343 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Soft Tissue Sarcoma
Mesothelioma

Interventions

DRUG: Azacitidine
DRUG: Temozolomide

Sponsor

Columbia University

Collaborators

[object Object]
[object Object]